EHealthcare Solutions finds HCP identity resolution drives 32% reach variance

The findings indicate that the technical infrastructure behind programmatic execution is as critical as the audience data itself. For streaming and digital media buyers, this means that high-value niche segments like medical specialists require deterministic identity matching to avoid wasted spend on unidentifiable users. As the industry moves toward verified provider identities, platforms that integrate deep identity graphs with diverse inventory sources will likely outperform those relying on generic exchanges. Watch for media planners to demand projected unique reach audits against original NPI lists as a standard pre-campaign requirement to validate platform efficiency.

eHealthcare Solutions operates within a growing ecosystem of healthcare-focused identity and data providers competing for pharma ad budgets. Throtle expanded its HCP identity graph in early 2026 by integrating National Provider Identifier data with real-time behavioral signals across digital channels, positioning itself as a deterministic matching layer for programmatic campaigns targeting physicians, nurses, and pharmacists. OptimizeRx, which acquired Practice Fusion's EHR data assets in 2024, has similarly built out its provider identity infrastructure to support point-of-care and programmatic activation for life sciences clients. Definitive Healthcare, meanwhile, continues to supply reference data on provider affiliations and specialties that underpin audience segmentation for these campaigns. The regulatory and business environment for HCP-targeted advertising has tightened considerably. The FDA's Office of Prescription Drug Promotion has increased scrutiny on digital pharma marketing claims, and the IAB Tech Lab published updated guidance in March 2026 on identity resolution standards for regulated industries, recommending that advertisers in healthcare and financial services require deterministic matching documentation before campaign launch. Separately, the American Medical Association updated its guidelines on physician data usage in commercial contexts, reinforcing that NPI numbers alone do not constitute consent for targeted advertising. These developments push platforms like eHealthcare Solutions to demonstrate compliance-ready identity verification as a competitive differentiator when pitching to pharma media teams. Technical benchmarks for HCP identity resolution remain sparse, but available data underscores the variance problem. A 2025 study by the Association of National Advertisers found that deterministic identity matching for niche professional audiences yielded addressable rates between 40% and 72% depending on the data provider and exchange used, a range consistent with the 32% variance eHealthcare Solutions reports. In adjacent verticals, LiveRamp's RampID has become the default identity backbone for many programmatic healthcare campaigns, though its match rates for HCP segments have drawn criticism from independent buyers who report gaps when cross-referencing against state medical board registries. The broader shift toward pharma contextual targeting and privacy-preserving measurement in pharma marketing further complicates identity resolution, as platforms must now reconcile deterministic provider matching with consent-based data activation under state privacy laws like the California Consumer Privacy Act.